Prediction and rate of infections in diabetes mellitus patients with diabetes ketoacidosis in Penang, Malaysia


Study aimed to determine the rate and prediction of infection in diabetes mellitus patients ≥18 year, with diabetic ketoacidosis (DKA). Retrospective cohort study design was adopted to achieve the objectives. Universal sampling technique was employed for data collection among Diabetes ketoacidosis patients, over a period of 3 years (Jan 2008-Dec 2010). Statistical package for social sciences used to analyze data. Over a 3-year period, total of 967 admissions were identified. Of it, 112 (11.6%) with no infection, 679 (70.2%) with bacterial infection and 176 (18.2%) with presumed viral infection. The mean WBC for all the patients was 18,177 (±9431). 721 (74.6%) had leukocytosis, as defined by a WBC ≥ 15,000/mm3. WBC, differential, leukocytosis, as well as sex, temperature were not significant predictors (p > 0.05) of bacterial infection. There was significant (p < 0.05) difference of age between the 3 groups, age above 57 years have high rate of infection as compared to age below and equal 57 years. The infection rate in elderly patients with DKA was high and majority of them had lack of clinical evidence. Major bacterial infections with potential serious sequel were particularly common (33.3%), among every third patient being presumed to have serious consequences.

Share and Cite:

Gillani, S. , Sulaiman, S. and Sundram, S. (2012) Prediction and rate of infections in diabetes mellitus patients with diabetes ketoacidosis in Penang, Malaysia. Open Journal of Epidemiology, 2, 1-6. doi: 10.4236/ojepi.2012.21001.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Umpierrez, G.E., Khajavi, M. and Kitabchi, A.E. (1996) Di-abetic ketoacidosis and hyperglycemic hyperosmolar syndrome. American Journal of the Medical Sciences, 311, 255-233. doi:10.1097/00000441-199605000-00006
[2] Kitabchi, A.E. and Nyenwi, E.A. (2006) Hyperglycemic crisis in diabetes mellitus: Diabetes ketoacidosis and hyperglycemic hyperosmolar state. Endocrinology & Metabolism Clinics of North America, 35, 725-751. doi:10.1016/j.ecl.2006.09.006
[3] Wagner, A., Risse, A., Brill, H.L., Wienhausen-Wilke, V., Rottmann, M., Sondern, K., et al. (1999) Therapy of severe diabetic ketoacidosis. Zero-mortality under very- low-dose insulin application. Diabetes Care, 22, 674-677. doi:10.2337/diacare.22.5.674
[4] Kitabchi, A.E. and Wall, B.M. (1995) Diabetic ketoacidosis. Medical Clinics of North America, 79, 9-37.
[5] Davoren, P. (1991) Precipitating fac-tors in diabetic ketoacidosis. Medical Journal of Australia, 154, 855-856.
[6] Foster, D.W. and MacGarry, J.D. (1983) The metabolic derangement and treatment of diabetic ketoacidosis. The New England Journal of Medicine, 309, 159-169. doi:10.1056/NEJM198307213090307
[7] Musey, V.C., Lee, J.K., Crawford, R., Klatka, M.A., Mc- Adams, D. and Philips, L. (1995) Diabetes in urban African-Americans: Cessation of insulin therapy is the major precipitating cause of diabetes ke-toacidosis. Diabetes Care, 18, 483-489. doi:10.2337/diacare.18.4.483
[8] BPSED Recommended DKA Guidelines.
[9] Slovis, C.M., Mork, V.G., Slovis, R.J. and Bain, R.P. (1987) Diabetes ketoacidosis and infection: Leukocyte count and differential as early predictors of serious infection. The American Journal of Emergency Medicine, 5, 1-5. doi:10.1016/0735-6757(87)90280-4
[10] Hoffman, W.H., Burek, C.L., Walker, J.L., Fisher, L.E., Khichi, M. and Mellick, L.B. (2003) Cytokine response to diabetic ketoacidosis and its treatment. Clinical Immunology, 108, 175-181. doi:10.1016/S1521-6616(03)00144-X
[11] Charfen, M.A. and Fernandez, F.M. (2005) Diabetes ketoacidosis. Emergency Medicine Clinics of North America, 23, 609-628. doi:10.1016/j.emc.2005.03.009
[12] Joshi, N., Caputo, G.M., Weitekamp, M.R. and Karchmer, M.W. (1999) Infections in patients with diabetes mellitus. The New England Journal of Medicine, 341, 1906-1912. doi:10.1056/NEJM199912163412507
[13] Delamaire, M., Maugendre, D., Moreno, M., LeGoff, M.C., Allannic, H. and Genetet, B. (1997) Impaired Leukocyte functions in diabetic patients. Diabetic Medicine, 14, 29- 34. doi:10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V
[14] Gallacher, S.J., Thomson, G., Fraser, W.D., Fisher, B.M., Gemmel, C.G. and MacCuish, A.C. (1995) Neu-trophil bactericidal function in diabetes mellitus: Evidence for association with blood glucose control. Diabetic Medicine, 12, 916-920. doi:10.1111/j.1464-5491.1995.tb00396.x
[15] Muchova, J., Liptakova, A., Orszaghova, Z., Garaiova, I., Tison, P., Carsky, J., et al. (1999) Antioxidant systems in polymorphonuclear leukocytes of type 2 diabetes mellitus. Diabetic Medicine, 16, 74-78. doi:10.1046/j.1464-5491.1999.00015.x
[16] Gomez, D.R., Rivera, M.R., Ramos, R.R., Reza, A.A., Gomez, P.F. and Rull, J. (1996) Diabetic ketoacidosis in adults: Clinical and laboratory features. Archives of Med- ical Research, 27, 177-181.
[17] Zukin, D.D., Garisham, J.E. and Saulys, A. (1998) Fever in children. In: Rosen, P., Barkin, R. and Danzi, D., Eds., Emergency Medicine: Concepts and Clinical Practice, Mosby, St. Louis, 1088-1089.
[18] Hamilton, G. (1998) Ane-mia, polycythermia and white blood cell disorders. In: Rosen, P., Barkin, R. and Danzi, D., Eds., Emergency Medicine: Concepts and Clinical Practice, Mosby, St. Louis, 2072-2073.
[19] Steward, J., Collier, A., Patrick, A.W., Clarke, B.F. and Weir, D.M. (1991) Alterations in monocyte receptor function in type 1 diabetic patients with ketoacidosis. Diabetic Medicine, 8, 213-216. doi:10.1111/j.1464-5491.1991.tb01574.x
[20] Lebovitz, H.E. (1995) Diabetes ketoacidosis. Lancet, 345, 767-772. doi:10.1016/S0140-6736(95)90645-2
[21] Guerin, J.M., Meyer, P. and Segresta, J.M. (1987) Hypothermia in diabetes ketoa-cidosis. Diabetes Care, 10, 801- 802.
[22] Golden, S.H., Peart, V.C., Kao, W.H. and Brancati, F.L. (1999) Perioperative gly-caemic control and the risk of infections complication in a cohort of adults with diabetes. Diabetes Care, 22, 1408-1414. doi:10.2337/diacare.22.9.1408
[23] Dunger, D.B., Sperling, M.A., Acerini, C.L., Bolin, D.J., Daneman, D., Danne, T.P.A., et al. (2004) ESPE/WPES consensus statement on diabetic ketoacidosis. Archives of Disease in Childhood, 89, 188-194. doi:10.1136/adc.2003.044875
[24] Burris, A. (1986) Leuko-moid reaction associated with severe diabetic ketoacidosis. Southern Medical Journal, 79, 647-648. doi:10.1097/00007611-198605000-00037
[25] Kayashima, T., Yamaguchi, K., Akiyoshi, T., Nanimatsu, H., Aragaki, S. and Hosokawa, T.F. (1993) Leukemoid reaction associated with diabetic ketoacidosis—mea-su- rement of plasma level of gra-nulocyte colony-stimulating factor. Internal Medicine, 32, 869-871. doi:10.2169/internalmedicine.32.869

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.